Search Results - "Torrente Segarra, V"

Refine Results
  1. 1

    Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients? by Torrente-Segarra, V, Bergstra, SA, Solomon-Escoto, K, Da Silva, JAP, Veale, DJ, Al-Emadi, S, Huizinga, TWJ

    Published in Scandinavian journal of rheumatology (03-09-2018)
    “…Objective: To assess the association between smoking, anti-cyclic citrullinated peptide (anti-CCP) antibody status, and clinical efficacy of biological…”
    Get full text
    Journal Article
  2. 2

    Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus by Torrente-Segarra, V, Carbonell-Abelló, J, Castro-Oreiro, S, Manresa Domínguez, J M

    Published in Clinical and experimental rheumatology (01-11-2010)
    “…Systemic lupus erythematosus (SLE) is an autoimmune disease that may affect many organs, with musculoskeletal symptoms being the most common. Fibromyalgia (FM)…”
    Get full text
    Journal Article
  3. 3

    Denosumab mid-term densitometric gain in postmenopausal osteoporosis women in clinical practice: comment on “Variability of denosumab densitometric response in postmenopausal osteoporosis” by Torrente-Segarra, V., Roig-Vilaseca, D.

    Published in Rheumatology international (01-06-2018)
    “…We aim to confirm previous observations among postmenopausal osteoporotic women who received denosumab in terms of densitometric changes. We performed an…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Joint ultrasound baseline abnormalities predict a specific long-term clinical outcome in systemic lupus erythematosus patients by Corzo, P, Salman-Monte, T C, Torrente-Segarra, V, Polino, L, Mojal, S, Carbonell-Abelló, J

    Published in Lupus (01-06-2017)
    “…Objective To describe long-term clinical and serological outcome in all systemic lupus erythematosus (SLE) domains in SLE patients with hand arthralgia (HA)…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study by Muñoz-Ortego, J, Torrente-Segarra, V, Prieto-Alhambra, D, Salman-Monte, TC, Carbonell-Abello, J

    “…Objectives: Over the past few years researchers have suggested that vitamin D plays a diverse role in autoimmune diseases such as systemic lupus erythematosus…”
    Get full text
    Journal Article
  8. 8

    Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs by NARVAEZ, J, DIAZ-TORNE, C, RUIZ, J. M, HERNANDEZ, M. V, TORRENTE-SEGARRA, V, ROS, S, RODRIGUEZ DE LA SERNA, A, DIAZ-LOPEZ, C, SANMARTI, R, NOLLA, J. M

    Published in Clinical and experimental rheumatology (01-11-2011)
    “…Identifying early predictors of response to biological agents is important for both the individual patient and health economics. The aim here was to identify…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Psoriatic Arthritis: What the Dermatologist Needs to Know, Part 2 by López-Ferrer, A., Torrente-Segarra, V., Puig, L.

    Published in Actas dermo-sifiliográficas (English ed.) (01-11-2010)
    “…This review aims to cover all aspects related to the treatment of psoriatic arthritis and the evaluation of the response to treatment. We define the various…”
    Get full text
    Journal Article
  12. 12

    Clinical, biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab by Torrente-Segarra, V, Lisbona-Pérez, MP, Rotes-Sala, D, Castro-Oreiro, S, Carbonell-Abelló, J

    Published in Lupus (01-03-2009)
    “…Systemic lupus erythematosus (SLE) is a multiorganic autoimmune disease that affects skin, osteoarticular and kidney frequently. Rituximab showed efficacy in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20